Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 16.1 EX-16.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- EX-FILING FEES Calculation of Filing Fee Tables
Associated filings
BRTH similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use of our auditor’s report dated February 28, 2024, with respect to the consolidated financial statements of Breathe BioMedical Inc. (the “Company”) as at December 31, 2023 and 2022 and for each of the years in the three-year period ended December 31, 2023, in the Registration Statement on Form F-1 of the Company dated June 7, 2024, as filed with the United Stated Securities and Exchange Commission.
We also consent to the reference to our firm under the heading “Experts” in the Registration Statement on Form F-1.
/s/ MNL LLP
Chartered Professional Accountants
Licensed Public Accountants
Toronto, Canada
June 7, 2024